PTH and Hypocalcemia: Furthermore, the pre-treatment levels of albumin-adjusted serum calcium and creatinine are the strongest predictors in denosumab-related hypocalcemia, but sex, age, vitamin D, PTH, alkaline phosphatase, or prior osteoporosis treatment do not have predictive value [41].